Medicare patients deserve devices that work. In a Washington Times letter to the editor, Professors David Simon and Hooman Noorchashm, co-directors of the Amy J. Reed Collaborative for Medical Device Safety, push back on AdvaMed's calls to fast-track reimbursement for FDA breakthrough devices — arguing the federal government should not pay for hastily cleared devices until they are proven safe and effective.
